2026 Immune Response Small Molecule Virus 
Drug Discovery World
SEPTEMBER 6, 2022
In gene therapy, re-engineered adeno-associated virus (AAV) vectors have been produced using various methods such as machine learning or directed evolution. The Cell and Gene Therapy Skills Demand Survey Report predicts a demand of 10,000 bioprocessing jobs in the UK by 2026. . Carlo Russo, CEO of Genenta.? .
The Pharma Data
SEPTEMBER 15, 2020
27 key programs highlighted, including assets that could potentially contribute revenue by 2025 and others in the 2026-2028 time frame. Based on the acceptable safety profile and the favorable immune response data, including the 4th dose response data, Pfizer received Breakthrough Therapy Designation. for RSV A and 18.0
Expert insights. Personalized for you.
130 
Let's personalize your content